Literature DB >> 24677664

Differences among admitting departments in alerts and alert overrides for drug-drug interaction.

Eun Kyoung Ahn1, Hye Jin Kam, Dong Kyun Park, Eun Young Jung, Youngho Lee, Rae Woong Park.   

Abstract

OBJECTIVE: To determine differences in the incidence and risk factors of alerts for drug-drug interaction (DDI) and the rate of alert overrides by an admitting department.
METHODS: A retrospective cohort study was performed using electronic health records of a Korean tertiary teaching hospital including all hospitalized adult patients for 18 months. The main outcome measures included incidence rates of alerts for DDI and their override, hazard ratios (HRs) for DDI alerts, and odds ratios (ORs) for alert overrides by admitting department (emergency department [ED], general ward [GW], and intensive care unit [ICU]) after adjusting for other known risk factors.
RESULTS: Among 102 379 incident admissions, 6060 had alerts for DDI (5.4/person-year). After adjusting for covariates, patients admitted to the ED (HR, 4.02; confidence interval [CI], 3.69-4.38) or ICU (HR, 1.62; CI, 1.29-2.04) showed higher risks for DDI compared with those admitted to the GW. The alert-override rate was significantly higher in the ED (OR 1.68) than in the GW; however, there was no significant difference between GW and ICU. The prevalence of DDI alerts and their override rate were also demonstrated. DISCUSSION: The incidence of DDI and the alert-override rate differed by admitting department. The ED and ICU were associated with higher risks for alerts on DDI than did the GW after adjusting for other known risk factors.
CONCLUSIONS: Admitting department was an independent risk factor for alerts and alert overrides. Strategies to reduce alerts and alert overrides should consider the admitting department.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  clinical decision support systems; drug-drug interactions; electronic health records; pharmacoepidemiology

Mesh:

Year:  2014        PMID: 24677664     DOI: 10.1002/pds.3591

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  5 in total

Review 1.  Evaluation of Potential Drug-Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis.

Authors:  Mary Grace Fitzmaurice; Adrian Wong; Hannah Akerberg; Simona Avramovska; Pamela L Smithburger; Mitchell S Buckley; Sandra L Kane-Gill
Journal:  Drug Saf       Date:  2019-09       Impact factor: 5.606

2.  Differences of Reasons for Alert Overrides on Contraindicated Co-prescriptions by Admitting Department.

Authors:  Eun Kyoung Ahn; Soo-Yeon Cho; Dahye Shin; Chul Jang; Rae Woong Park
Journal:  Healthc Inform Res       Date:  2014-10-31

3.  Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment.

Authors:  Katharina Luise Schneider; Kathrin Kastenmüller; Klaus Weckbecker; Markus Bleckwenn; Miriam Böhme; Julia Carolin Stingl
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

4.  Assessment of the risk of QT-interval prolongation associated with potential drug-drug interactions in patients admitted to Intensive Care Units.

Authors:  Flávia Medeiros Fernandes; Aryelle Mayara da Silva Paulino; Bruna Camelo Sedda; Eliane Pereira da Silva; Rand Randall Martins; Antonio Gouveia Oliveira
Journal:  Saudi Pharm J       Date:  2018-11-10       Impact factor: 4.330

5.  Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand.

Authors:  Thananan Rattanachotphanit; Chulaporn Limwattananon; Onanong Waleekhachonloet
Journal:  Ther Adv Drug Saf       Date:  2019-01-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.